Main menu

Single-cell nanopore sequencing allows high-throughput multiomic analyses of cellular diversity in disease


Ghamdan Al-Eryani is currently completing his PhD in the Tumour Progression group located at the Garvan Institute of Medical Research in Sydney, Australia where he is developing and implementing single-cell technologies to understand how the immune system works in cancer.

During this webinar, Ghamdan shares his work using single-cell nanopore sequencing for high-throughput multiomic analyses of cellular diversity in disease.

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Nanopore technology

Subscribe to Nanopore updates Resources and publications What is the Nanopore Community

About Oxford Nanopore

News Company timeline Sustainability Leadership team Media resources & contacts For investors For partners Working at Oxford Nanopore Current vacancies Commercial information BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Spanish flag